Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

healthcare business deal

Boston Scientific to acquire medical device specialists focused on stroke prevention for $1.2B

Silk Road Medical is known for developing transcarotid artery revascularization (TCAR), a new-look procedure designed to reduce the risk of stroke in patients with carotid artery disease.

Thumbnail

Another common artificial sweetener linked to higher risk of heart attack, stroke

According to new research led by Cleveland Clinic cardiologists, consuming high levels of xylitol can significantly increase a person's three-year risk of experiencing a major adverse cardiac event. 

Newsweek ranked the 50 best heart hospitals in the world

3 in 5 US adults projected to have CVD by 2050, with a price tag of $1.8T—can cardiologists ‘turn the tide’?

More than 60% of adults in the United States are expected to have at least one form of cardiovascular disease by 2050, according to new data published by the American Heart Association. Fortunately, evidence does suggest that healthier lifestyles are starting to become more common as time goes on.

Richard Heuser, MD, an interventional cardiologist known for his groundbreaking work in the field, leadership and strong business acumen, died on May 23. He was 73 years old.

Cardiologist Richard Heuser, interventional specialist and medical device pioneer, dies at 73

Heuser had a long, impactful career in cardiology. One former colleague said he was “an amazing interventional cardiologist and an even better human being.”

Leftr, Pedro Martinez-Clark, MD, FSCAI, interventional cardiologist, founder and medical director of Amavita Heart and Vascular Health during a PAD intervention. Right, an ultrasound evaluation of PAD in the legs. Amavita recently launched the Miami Initiative to Stop Amputation (MISA) to tackle the rising rates of amputations due to peripheral artery disease (PAD), in Latin, Haitian and Black communities in the Miami area. Photos courtesy of Amavita Heart and Vascular Health

Rising amputation rates spark new PAD initiative in Miami

"When you think about the rise of amputations in a country like the United States, that's concerning because it should not be happening here," one interventional cardiologist said. 

AI-based CAD assessments dramatically improve vascular surgery outcomes

PAD patients evaluated with HeartFlow's noninvasive FFRCT Analysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years. 

the words "FDA recall" on a board

FDA announces new recall of delivery catheters after patient’s death

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

money business cash flow dollar

Medical device company raises $87M to study new-look scaffolds for BTK PAD

R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.